Image

A Combined Multidomain Intervention to Prevent Cognitive Decline Associated With Cardiovascular Risk Factors.

Recruiting
60 years of age
Both
Phase N/A

Powered by AI

Overview

The ACTIONcardioRisk trial is designed to investigate the effect of aerobic and progressive resistance training exercises combined with cognitive training, on neurocognitive functioning of sedentary older adults with and without cardiovascular risk factors.

Description

The proportion of older adults is on the rise in Canada, with the fastest growth recorded among those seventy years of age or older. The prevalence of cardiovascular risk factors (CVRF) such as diabetes, hypertension, and high cholesterol increases drastically with age. Individuals with CVRF often show impaired cognition, such as attention and memory deficits. In healthy older adults, exercise training and cognitive stimulation can help enhance cognitive performances. More precisely, combined intervention, including physical and cognitive training, has shown beneficial effects on cognition in older adults without cognitive impairment and with mild cognitive impairment. However, the effect of such programs on cognition in individuals with CVRF is not well documented. This project compares the effect of a physical exercise program, including aerobic and resistance training, alone or combined with cognitive training on cognitive performances and brain imaging outcomes in individuals with CVRF and healthy controls.

Eligibility

Inclusion Criteria:

  • Adult aged 60 and older,
  • Normal or corrected vision and normal hearing for their age range,
  • No cognitive impairment (Mini-Mental State Examination - MMSE ≥ 25),
  • Inactive (< 150 min of physical activity per week).

Exclusion Criteria:

  • MMSE ≤ 24 or diagnosis of dementia,
  • Uncontrolled psychological / psychiatric condition within the past 6 months,
  • Neurological disease,
  • Severe exercise intolerance,
  • Respiratory disease (e.g., asthma, COPD),
  • Excessive alcohol consumption (> 15 drinks/week),
  • Documented cerebral, peripheral or coronary atherosclerotic disease,
  • Chronic systolic or diastolic heart failure,
  • Symptomatic aortic stenosis,
  • Atrial fibrillation,
  • Automatic implantable defibrillator or permanent pacemaker,
  • Malignant exertional arrhythmias,
  • Non-cardiopulmonary limitation to exercise (e.g., arthritis).

Study details

Aging, Cardiovascular Risk Factor

NCT04962061

Louis Bherer

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.